C12Y 301/06001
Arylsulfatase
Official title: Arylsulfatase (3.1.6.1)
C12Y301/06001 (Arylsulfatase) appears on 18 US grants and 48 published applications in this corpus.
Search patents in C12Y- Granted patents
- 18
- Published applications
- 48
- Assignees
- 24
- Inventors
- 71
- Latest grant
- 9 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 1 | 3 |
| 2016 | 0 | 1 |
| 2017 | 1 | 3 |
| 2018 | 0 | 3 |
| 2019 | 1 | 2 |
| 2020 | 0 | 5 |
| 2021 | 1 | 3 |
| 2022 | 5 | 6 |
| 2023 | 2 | 7 |
| 2024 | 1 | 1 |
| 2025 | 4 | 6 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Mutated arylsulfatase a9 Sep 2025US 12,410,415 B2Rheinische Friedrich-Wilhelms-Universität Bonn
- Compositions useful in treatment of metachromatic leukodystrophy24 Jun 2025US 12,338,451 B2
- Methods for purification of arylsulfatase A3 Jun 2025US 12,319,940 B2Takeda Pharmaceutical Company Limited
- Biofertilizing bacterial strain15 Apr 2025US 12,275,677 B2Institut National de la Recherche Agronomique
- Methods for purification of arylsulfatase A30 Jan 2024US 11,884,945 B2Takeda Pharmaceutical Company Limited
- Anti-Human Transferrin Receptor Antibody Permeating Blood-Brain Barrier2 Jul 2026US 2026/0184781 A1JCR Pharmaceuticals Co., Ltd.
- Compositions useful in treatment of metachromatic leukodystrophy9 Oct 2025US 2025/0313859 A1The Trustees of the University of Pennsylvania
- Affinity chromatography using an elution buffer comprising glycine and arginine14 Aug 2025US 2025/0257339 A1Takeda Pharmaceutical Company Limited
- Compositions and methods for treating metachromatic leukodystrophy disease and related disorders17 Jul 2025US 2025/0228907 A1The Children’s Hospital of Philadelphia
- Compositions useful in treatment of metachromatic leukodystrophy5 Jun 2025US 2025/0177495 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Anti-human transferrin receptor antibody permeating blood-brain barrier5US 11,248,045 B2JCR Pharmaceuticals Co., Ltd. · 2022
- Compositions of beta-glucuronidase enzyme blends with enhanced enzymatic activity and methods of preparation thereof2US 11,268,079 B2Integrated Micro-Chromatography Systems, Inc. · 2022
- Mutated arylsulfatase A1US 11,459,550 B2Rheinische Frirdrich-Wilhelms-UniversitäT Bonn · 2022
- Compositions of beta-glucuronidase enzyme blends with enhanced enzymatic activity and methods of preparation thereof1US 11,807,879 B2Integrated Micro-Chromatography Systems, Inc. · 2023
- Enzyme preparations yielding a clean taste1US 9,011,948 B2Dsm IP Assets B.V. · 2015